Gommeren Kris, Desmas Isabelle, Garcia Alexandra, Bauer Natalie, Moritz Andreas, Roth Joachim, Peeters Dominique
Department of Clinical Sciences, School of Veterinary Medicine, University of Liège, Liège, Belgium.
Department of Veterinary Clinical Sciences, Clinical Pathology, and Clinical Pathophysiology, Justus-Liebig-University Giessen, Giessen, Germany.
J Vet Emerg Crit Care (San Antonio). 2018 Jan;28(1):9-19. doi: 10.1111/vec.12685. Epub 2017 Dec 13.
To evaluate C-reactive protein (CRP), interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-α) kinetics in dogs with a systemic inflammatory response syndrome (SIRS) presented to an emergency service. We hypothesized serum CRP concentrations would increase and vary during hospitalization, and would correlate with plasma IL-6 and TNF-α concentrations, vary in magnitude according to the underlying disease, and predict survival.
Prospective, observational, clinical study.
University emergency department.
Sixty-nine dogs with SIRS weighing over 5 kg who could tolerate the blood sampling.
Serum and plasma were collected (and stored at -80°C) at presentation (T0), after 6 (T6), 12 (T12), 24 (T24), and 72 (T72) hours, and at a follow-up visit at least 1 month after discharge (T1m). Underlying diseases were categorized as infection (I), neoplasia (N), trauma (T), gastric-dilation and volvulus (GDV), other gastrointestinal (GI), renal (R), and miscellaneous (M) disease.
Serum CRP concentration was measured using a canine-specific immunoturbidimetric assay. Biologically active plasma IL-6 and TNF-α concentrations were assessed using bioassays. Forty-four dogs survived, 8 died, and 17 were euthanized. Nineteen dogs had follow-up visits. At T0, serum CRP concentration was above the reference interval in 73.1% (49/67), and was within the reference interval (0-141.9 nmol/L) throughout hospitalization in only 6% (4/67). Serum CRP concentrations were significantly higher (P < 0.0001) at T0 (882.9 ± 1082.9 nmol/L) and at all time points during hospitalization (P < 0.0001) compared to T1m, with highest concentrations observed at T24 (906. 7 ± 859.0 nmol/L). At T1m, serum CRP concentrations were within the reference interval (22.9 ± 42.9 nmol/L) in 95% (18/19) of dogs. Logarithmic concentrations of serum CRP and plasma IL-6 were significantly correlated (P < 0.001, r = 0.479). None of the measured cytokines were associated with disease category or outcome.
Serum CRP concentration is increased in dogs with SIRS, and decreases during treatment and hospitalization. Serum CRP, plasma IL-6, and plasma TNF-α concentrations cannot predict outcome in dogs with SIRS.
评估就诊于急诊的患有全身炎症反应综合征(SIRS)的犬的C反应蛋白(CRP)、白细胞介素6(IL-6)和肿瘤坏死因子α(TNF-α)的动力学变化。我们假设血清CRP浓度在住院期间会升高且有变化,并且与血浆IL-6和TNF-α浓度相关,会因潜在疾病的不同而有幅度差异,且能预测生存情况。
前瞻性、观察性临床研究。
大学急诊科。
69只体重超过5 kg且能耐受采血的患有SIRS的犬。
在就诊时(T0)、6小时(T6)、12小时(T12)、24小时(T24)、72小时(T72)以及出院后至少1个月的随访时(T1m)采集血清和血浆(并储存于-80°C)。潜在疾病分为感染(I)、肿瘤(N)、创伤(T)、胃扩张扭转(GDV)、其他胃肠道(GI)、肾脏(R)和其他杂项(M)疾病。
采用犬特异性免疫比浊法测量血清CRP浓度。使用生物测定法评估具有生物活性的血浆IL-6和TNF-α浓度。44只犬存活,8只死亡,17只实施安乐死。19只犬进行了随访。在T0时,73.1%(49/67)的犬血清CRP浓度高于参考区间,仅6%(4/67)的犬在整个住院期间血清CRP浓度均在参考区间(0 - 141.9 nmol/L)内。与T1m相比,T0时(882.9 ± 1082.9 nmol/L)及住院期间所有时间点血清CRP浓度均显著更高(P < 0.0001),在T24时观察到最高浓度(906.7 ± 859.0 nmol/L)。在T1m时,95%(18/19)的犬血清CRP浓度在参考区间(22.9 ± 42.9 nmol/L)内。血清CRP和血浆IL-6的对数浓度显著相关(P < 0.001,r = 0.479)。所测细胞因子均与疾病类别或结局无关。
患有SIRS的犬血清CRP浓度升高,在治疗和住院期间降低。血清CRP、血浆IL-6和血浆TNF-α浓度不能预测患有SIRS的犬的结局。